AcelRx becomes Talphera, adopting new name to reflect pain pivot - FiercePharma
| TLPH Stock | 0.64 0.02 3.23% |
Under 72 percent of all Talphera's traders are curious in acquiring. The analysis of overall sentiment of trading Talphera stock suggests that a large number of investors are confidant at this time. Talphera's investing sentiment shows overall attitude of investors towards Talphera.
Talphera |
AcelRx becomes Talphera, adopting new name to reflect pain pivot FiercePharma
Read at news.google.com
 |
Talphera Fundamental Analysis
We analyze Talphera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talphera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talphera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Talphera is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Talphera Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talphera stock to make a market-neutral strategy. Peer analysis of Talphera could also be used in its relative valuation, which is a method of valuing Talphera by comparing valuation metrics with similar companies.
Peers
Talphera Related Equities
| TEVA | Teva Pharma | 3.66 | ||||
| EBS | Emergent Biosolutions | 0.50 | ||||
| NBIX | Neurocrine Biosciences | 0.34 | ||||
| HLN | Haleon Plc | 0.10 | ||||
| ALVO | Alvotech | 1.65 |
Complementary Tools for Talphera Stock analysis
When running Talphera's price analysis, check to measure Talphera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Talphera is operating at the current time. Most of Talphera's value examination focuses on studying past and present price action to predict the probability of Talphera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Talphera's price. Additionally, you may evaluate how the addition of Talphera to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |